Thomas Galloway, MD
Radiation Oncology · Philadelphia, PANPI 1710052212
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,960 of the $12,425 with a category attached, or 88.2%. 7 manufacturers reported payments, led by Varian Medical Systems, Inc. at 46.0% of the total. Among radiation oncology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $887.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Varian Medical Systems, Inc.$6K
- Siemens Medical Solutions USA, Inc.$5K
- Merck Kgaa$2K
- Sirtex Medical Inc$189
- Brainlab, Inc.$27
- Gilead$23
- plus $19 from 1 others
Across 12 payments — averaging $4611.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cardinal Health 414 LLC$55K
What the payments were for
- Consulting fees$10,96088%
- Travel & lodging$1,1639%
- Food & beverage$3022%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Varian Medical Systems, Inc. | 3 | $5,710 |
| Siemens Medical Solutions USA, Inc. | 5 | $4,807 |
| Merck Kgaa | 2 | $1,650 |
| Sirtex Medical Inc | 1 | $189 |
| Brainlab, Inc. | 1 | $27 |
| Gilead | 1 | $23 |
| Cardinal Health 414 LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueBeam$4,763
- Other$4,670
- SIR-Spheres Microspheres$189
How this compares
$12,425 in reported general payments places this provider in the 90th percentile of 339 radiation oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 44 | $5,483 |
| Gabapentin | 31 | $596 |
| Pilocarpine Hcl | 15 | $560 |
| Oxycodone Hcl | 35 | $545 |
| Lidocaine Hcl ViscousLidocaine Hcl | 20 | $418 |
| Ondansetron Hcl | 14 | $118 |
| Lorazepam | 14 | $80 |
| Tramadol Hcl | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Philadelphia
- Neil TaunkPhiladelphia$203K
- Wenyin ShiPhiladelphia$119K
- Kevin NeadPhiladelphia$50K
- Adam DickerPhiladelphia$46K
- Tinatin ChabrashviliPhiladelphia$39K
- Bryan PukenasPhiladelphia$36K
- Sameera KumarPhiladelphia$29K
- Joshua MeyerPhiladelphia$25K
- Abigail BermanPhiladelphia$25K
- Michelle Alonso-BasantaPhiladelphia$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.